Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 3/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | G6PD | P11413 | 1/20 | 0.31 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.31 |
| ▸ | IL1B | P01584 | 1/20 | 0.30 |
| ▸ | EED | O75530 | 1/20 | 0.30 |
| ▸ | SUZ12 | Q15022 | 1/20 | 0.30 |
| ▸ | EZH2 | Q15910 | 1/20 | 0.30 |
| ▸ | EPAS1 | Q99814 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27704529 | 0.89 | SMN1; SMN2 (0.35) | SMN1; SMN2CYP1A2HIF1AMEN1KMT2A | |
| SCHEMBL28038102 | 0.77 | SMN1; SMN2 (0.34) | SMN1; SMN2ALDH1A1NPSR1MAPT | |
| SCHEMBL38652270 | 0.74 | SMN1; SMN2 (0.34) | SMN1; SMN2HIF1AALDH1A1NPSR1MAPT | |
| SCHEMBL8086329 | 0.70 | KDM4E (0.35) | CYP1A2MEN1KMT2AALDH1A1KDM4E | |
| SCHEMBL8089735 | 0.70 | CYP1A2 (0.35) | SMN1; SMN2CYP1A2HIF1AMEN1KMT2A | |
| SCHEMBL6902793 | 0.68 | EED (0.41) | SMN1; SMN2HIF1AMEN1KMT2AALDH1A1 | |
| SCHEMBL6838800 | 0.68 | CA1 (0.35) | KMT2A | |
| SCHEMBL21114902 | 0.67 | SMN1; SMN2 (0.38) | SMN1; SMN2CYP1A2HIF1AMEN1KMT2A | |
| SCHEMBL2691519 | 0.66 | — | — | |
| SCHEMBL5352623 | 0.65 | EED (0.42) | SMN1; SMN2HIF1AMEN1KMT2ANPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3416943-B1 | ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2020-04-01 | — | — | EP | disclosed |
| US-10343971-B2 | Crotonates having use in perfumery | GIVAUDAN SA (CH) | 2019-07-09 | — | — | US | disclosed |
| US-20190023643-A1 | Organic Compounds | GIVAUDAN SA (CH) | 2019-01-24 | — | — | US | disclosed |
| CN-104744409-A | Method for manufacturing oxetane compound, method for manufacturing azolylmethylcyclopentanol compound, and intermediate compound | KUREHA CORP | 2015-07-01 | — | — | CN | disclosed |
| CN-104744315-A | METHOD FOR MANUFACTURING OXETANE COMPOUND, METHOD FOR MANUFACTURING AZOLYLMETHYLCYCLOPENTANOL COMPOUND, AND INTERMEDIATE COMPOUND | KUREHA CORP | 2015-07-01 | — | — | CN | disclosed |
| CN-103764636-A | Method for producing oxetane compound, method for producing azolylmethylcyclopentanol compound, and intermediate compound | KUREHA CORP | 2014-04-30 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10343971-B2 | Crotonates having use in perfumery | CROCC, PAX3, H1-3 | SMN1; SMN2 1848/4885CYP1A2 1733/4885HIF1A 756/4885 |
| US-20190023643-A1 | Organic Compounds | OR10J3, H1-4, H1-0 | SMN1; SMN2 3239/4885CYP1A2 236/4885HIF1A 1376/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.